Curated News: The Lancet

Filters close
Newswise: Raising awareness of Long Covid ‘blue legs’ symptom
Released: 14-Aug-2023 1:20 PM EDT
Raising awareness of Long Covid ‘blue legs’ symptom
University of Leeds

An unusual case of a Long Covid patient’s legs turning blue after 10 minutes of standing highlights the need for greater awareness of this symptom among people with the condition, according to new research published in the Lancet.

10-Aug-2023 12:10 PM EDT
"The Israeli Override Clause: Threatening the Health in All Policies Approach"
George Washington University

On July 24, 2023, Israel's Parliament sanctioned a substantial amendment to the Basic Law, prompting apprehensions regarding power equilibrium and its potential influence on public well-being. In response, a coalition of prominent Israeli and global public health experts has united to dissect the profound ramifications of this revision.

   
Released: 19-Jul-2023 12:00 PM EDT
MD Anderson Research Highlights for July 19, 2023
University of Texas MD Anderson Cancer Center

The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.

   
Released: 13-Jul-2023 5:30 PM EDT
New talking therapy for depression could be more effective and cheaper than CBT
University of Exeter

A new talking therapy for depression has shown encouraging early signs of being more effective and cheaper to deliver than the current best practice of Cognitive Behavioural Therapy (CBT).

Released: 12-Jul-2023 1:15 PM EDT
Research uncovers why people who have Down’s Syndrome age prematurely
Queen Mary University of London

The molecular processes responsible for natural ageing of cells are poorly understood. Studying conditions in humans where ageing is accelerated due to genetic causes presents opportunities to learn about the mechanisms that control ageing and devise strategies to slow down the ageing process.

Newswise: Significant variations in hip fracture health costs and care between NHS hospitals and regions, study finds
10-Jul-2023 8:25 AM EDT
Significant variations in hip fracture health costs and care between NHS hospitals and regions, study finds
University of Bristol

There are significant variations in healthcare spending and care delivery across NHS hospitals in England and Wales following hip fracture, a new University of Bristol-led study aimed at understanding how hospital care impacts patients’ outcomes and costs has revealed.

Newswise: Pediatric Early Warning Systems save lives in Latin American hospitals
Released: 10-Jul-2023 8:15 AM EDT
Pediatric Early Warning Systems save lives in Latin American hospitals
St. Jude Children's Research Hospital

Scientists at St. Jude Children’s Research Hospital and colleagues in Latin America found that early identification of clinical deterioration saves lives, especially in hospitals with the greatest need.

Released: 6-Jul-2023 11:15 AM EDT
Wastewater monitoring could act as pandemic early warning system
Murdoch Childrens Research Institute

Wastewater monitoring could act as an early warning system to help countries better prepare for future pandemics, according to a new study.

   
5-Jul-2023 8:50 AM EDT
Lack of sleep lessens cognitive benefits of physical activity
University College London

Regular physical activity may protect against cognitive decline as we get older, but this protective effect may be diminished for people who are not getting enough sleep, according to a new study by UCL researchers.

15-Jun-2023 2:20 PM EDT
Patients with refractory metastatic colorectal cancer experience survival benefits with fruquintinib
University of Texas MD Anderson Cancer Center

Researchers from The University of Texas MD Anderson Cancer Center reported study results showing that the targeted therapy fruquintinib significantly improved overall survival (OS) and progression-free survival (PFS) in patients with refractory metastatic colorectal cancer. Findings from the global FRESCO-2 trial, published today in The Lancet, were first presented at the European Society for Medical Oncology (ESMO) Congress 2022.

Released: 9-Jun-2023 3:25 PM EDT
Study shows metformin lowers the risk of getting long COVID
University of Minnesota Medical School

In a new study published in The Lancet Infectious Diseases, University of Minnesota researchers found that metformin, a drug commonly used to treat diabetes, prevents the development of long COVID.

1-Jun-2023 3:20 PM EDT
Children With Drug-Resistant Epilepsy Live Longer After Cranial Surgery
Ann and Robert H. Lurie Children's Hospital of Chicago

Survival rate beyond 10 years in children with drug-resistant epilepsy (DRE) was highest after cranial epilepsy surgery and lowest when treated only with antiseizure medications, according to a study published in The Lancet Child and Adolescent Health. This large, retrospective study was the first to compare long-term survival in children with DRE among cohorts treated with medications only, vagus nerve stimulation plus medications, and cranial epilepsy surgery plus medications. Results show that risk of early death was reduced by over 80 percent after surgery and by 40 percent after vagus nerve stimulation, compared to medication-only treatment.

Newswise: ASCO: Targeted therapy induces responses in HER2-amplified biliary tract cancer
31-May-2023 3:20 PM EDT
ASCO: Targeted therapy induces responses in HER2-amplified biliary tract cancer
University of Texas MD Anderson Cancer Center

An MD Anderson-led Phase II trial showed the HER2-targeted therapy zanidatamab demonstrated durable responses in patients with advanced HER2-positive biliary tract cancer. The data were presented at the 2023 ASCO Annual Meeting.

Released: 15-May-2023 1:00 PM EDT
Clinically relevant deficiency of the “bonding hormone” oxytocin demonstrated
University of Basel

The hormone oxytocin is important for social interaction and to control emotions. A deficiency of this hormone has previously been assumed in various diseases such as autism, but has never been proven.

Released: 12-May-2023 4:25 PM EDT
Cervical cancer screening doubles when under-screened women are mailed testing kits
UNC Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill

Researchers at the UNC Gillings School of Global Public Health and UNC Lineberger Comprehensive Cancer Center found mailing human papillomavirus (HPV) self-collection tests and offering assistance to book in-clinic screening appointments to under-screened, low-income women improved cervical cancer screening nearly two-fold compared to scheduling assistance alone.

Newswise: New Study Shows Trastuzumab Deruxtecan Improves Survival for Patients with HER2-positive Metastatic Breast Cancer
Released: 3-May-2023 12:00 PM EDT
New Study Shows Trastuzumab Deruxtecan Improves Survival for Patients with HER2-positive Metastatic Breast Cancer
Yale Cancer Center/Smilow Cancer Hospital

A new phase III study has demonstrated the efficacy of trastuzumab deruxtecan (Enhertu) in patients with HER2-positive metastatic breast cancer whose cancers were resistant to previous treatment with trastuzumab emtansine. Both trastuzumab deruxtecan and trastuzumab emtansine are antibody-drug conjugates, a relatively new type of drug that delivers chemotherapy directly to the cancer cell, minimizing damage to normal tissues.

Released: 21-Apr-2023 7:05 PM EDT
Surgery most effective treatment of metabolic liver disease
King's College London

Metabolic (bariatric) surgery is more effective than medications and lifestyle interventions for the treatment of advanced non-alcoholic fatty liver disease.

Released: 19-Apr-2023 3:25 PM EDT
Minimum unit pricing for alcohol associated with a 13% decrease in deaths from alcohol consumption in Scotland, study suggests
The Lancet

The implementation of minimum unit pricing (MUP) legislation is associated with significant reductions in alcohol-specific deaths among those from the most socio-economically deprived areas in Scotland, suggests a new study published in The Lancet.

   
Released: 14-Apr-2023 2:40 PM EDT
Hearing aids may protect against a higher risk of dementia associated with hearing loss, study suggests
Lancet

People experiencing hearing loss who are not using a hearing aid may have a higher risk of dementia than people without hearing loss, suggests a new study published in The Lancet Public Health journal. However, using a hearing aid may reduce this risk to the same level as people without hearing loss.



close
1.78338